AU2003285946A8 - Identification of antimycobacterial targets and the inhibition thereof as a treatment for infectious diseases - Google Patents

Identification of antimycobacterial targets and the inhibition thereof as a treatment for infectious diseases

Info

Publication number
AU2003285946A8
AU2003285946A8 AU2003285946A AU2003285946A AU2003285946A8 AU 2003285946 A8 AU2003285946 A8 AU 2003285946A8 AU 2003285946 A AU2003285946 A AU 2003285946A AU 2003285946 A AU2003285946 A AU 2003285946A AU 2003285946 A8 AU2003285946 A8 AU 2003285946A8
Authority
AU
Australia
Prior art keywords
antimycobacterial
targets
inhibition
identification
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003285946A
Other versions
AU2003285946A1 (en
Inventor
Edward Weinstein
Harvey Rubin
David Howard Avarbock
Andrew Brian Avarbock
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Pennsylvania Penn
Original Assignee
University of Pennsylvania Penn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Pennsylvania Penn filed Critical University of Pennsylvania Penn
Publication of AU2003285946A1 publication Critical patent/AU2003285946A1/en
Publication of AU2003285946A8 publication Critical patent/AU2003285946A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AU2003285946A 2002-10-22 2003-10-22 Identification of antimycobacterial targets and the inhibition thereof as a treatment for infectious diseases Abandoned AU2003285946A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US42013102P 2002-10-22 2002-10-22
US60/420,131 2002-10-22
PCT/US2003/033524 WO2004037192A2 (en) 2002-10-22 2003-10-22 Identification of antimycobacterial targets and the inhibition thereof as a treatment for infectious diseases

Publications (2)

Publication Number Publication Date
AU2003285946A1 AU2003285946A1 (en) 2004-05-13
AU2003285946A8 true AU2003285946A8 (en) 2004-05-13

Family

ID=32176517

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2003285946A Abandoned AU2003285946A1 (en) 2002-10-22 2003-10-22 Identification of antimycobacterial targets and the inhibition thereof as a treatment for infectious diseases
AU2003294235A Abandoned AU2003294235A1 (en) 2002-10-22 2003-10-22 Fragments and activity of rel protein in m. tuberculosis adn other uses thereof

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2003294235A Abandoned AU2003294235A1 (en) 2002-10-22 2003-10-22 Fragments and activity of rel protein in m. tuberculosis adn other uses thereof

Country Status (2)

Country Link
AU (2) AU2003285946A1 (en)
WO (2) WO2004037997A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2246349A1 (en) * 2009-04-20 2010-11-03 BKG Pharma ApS Treatment of infectious diseases
ME02847B (en) 2009-07-27 2018-01-20 Gilead Sciences Inc Fused heterocyclic compounds as ion channel modulators
CA2802288C (en) 2010-07-02 2018-08-21 Gilead Sciences, Inc. Triazolopyridinone compounds as ion channel modulators
NZ617987A (en) 2011-05-10 2016-02-26 Gilead Sciences Inc Fused heterocyclic compounds as sodium channel modulators
NO3175985T3 (en) 2011-07-01 2018-04-28
TWI478908B (en) 2011-07-01 2015-04-01 Gilead Sciences Inc Fused heterocyclic compounds as ion channel modulators
WO2013043744A2 (en) 2011-09-21 2013-03-28 Inception 1, Inc. Tricyclic compounds useful as neurogenic and neuroprotective agents
CN103232447B (en) * 2013-04-02 2015-06-03 陕西科技大学 3-acetyl-5-acetylimino-2-(N-phenothiazinyl)-1,3,4-thiadiazole, and preparation method and application thereof
GB2566516A (en) 2017-09-15 2019-03-20 Univ Oxford Innovation Ltd Electrochemical recognition and quantification of cytochrome c oxidase expression in bacteria
CN109385439A (en) * 2018-09-18 2019-02-26 上海晶诺生物科技有限公司 The one recombination TM4 phage library and its application for constructing nadh dehydrogenase gene family missing mycobacterium tuberculosis
WO2023201199A2 (en) * 2022-04-11 2023-10-19 The Johns Hopkins University Tuberculosis vaccines

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5834279A (en) * 1996-03-07 1998-11-10 Trustees Of The University Of Pennsylvania Methods of identifying compounds that inhibit DNA synthesis in mycobacterium tuberculosis and compositions, reagents and kits for performing the same

Also Published As

Publication number Publication date
AU2003294235A1 (en) 2004-05-13
WO2004037997A2 (en) 2004-05-06
WO2004037997A3 (en) 2004-11-18
AU2003285946A1 (en) 2004-05-13
WO2004037192A2 (en) 2004-05-06
AU2003294235A8 (en) 2004-05-13
WO2004037192A3 (en) 2006-09-14

Similar Documents

Publication Publication Date Title
ZA200501913B (en) New compounds for the inhibition of rotamases and use thereof
HRP20040906B1 (en) Bisphosphonic acid for the treatment and prevention of ostreoporosis
AU2003291992A1 (en) Phenylethanolamine derivatives for the treatment of respiratory diseases
HK1086488A1 (en) Compound and use thereof for the treatment of cancer
AU2002366355A1 (en) SEQUESTRATION OF ABeta IN THE PERIPHERY IN THE ABSENCE OF IMMUNOMODULATING AGENT AS A THERAPEUTIC APPROACH FOR THE TREATMENT OR PREVENTION OF BETA-AMYLOID RELATED DISEASES
AU2003256253A8 (en) Aerosol for medical treatment and methods
AU2003235613A1 (en) Crude drug compositions for treating or preventing arthritic diseases and the preparation process
IL196301A0 (en) Medicament for the treatment of hapatitis c
IL159344A0 (en) Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease
IL158181A0 (en) N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity
IL161070A0 (en) Compositions for the treatment of infectious diseases
HUP0401605A3 (en) Integrin inhibitors for the treatment of eye diseases
EP1520043A4 (en) METHODS FOR THE IDENTIFICATION OF IKKa FUNCTION AND OTHER GEN ES USEFUL FOR TREATMENT OF INFLAMMATORY DISEASES
AU2003285946A8 (en) Identification of antimycobacterial targets and the inhibition thereof as a treatment for infectious diseases
AU2003258145A8 (en) Substituted phenylindoles for the treatment of hiv
GB0004531D0 (en) The treatment of respiratory diseases
AU2002220266A1 (en) Methods for the identification and the treatment of cardiovascular disease
GB0201025D0 (en) The treatment of degenerative diseases
AP2005003344A0 (en) A group of nucleic acid fragments for prevention of HIV infection or AIDS and the usage thereof
GB0028484D0 (en) Imidazolone derivatives for the treatment of viral diseases
AU6274101A (en) Medicines for the prevention and treatment of neurodegenerative diseases
AU2003287388A8 (en) Inhibition of hiv-1 replication
AU2002343085A1 (en) Tnf-alpha inhibitors for the treatment of hepatic diseases
AU2003210386A1 (en) Pharmaceutical composition comprising a bisphosphonate and a cox-2 inhibitor for the treatment of bone diseases
AU2003213700A1 (en) Immunogens for treatment of neoplastic and infectious disease

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase